<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of granuloma faciale in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of granuloma faciale in adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">Treatment of granuloma faciale in adults</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Granuloma faciale is benign; however, the chronicity and appearance of granuloma faciale often prompt treatment. Treatment efficacy data are limited. Other therapeutic approaches may be reasonable. Refer to UpToDate content on granuloma faciale for details on dosing and treatment regimens.</div><div class="graphic_footnotes"><p>G6PD: glucose-6-phosphate dehydrogenase.</p>
<p>* Topical tacrolimus is our preferred initial treatment based on a low likelihood of cosmetically significant adverse effects.</p>
<p>¶ We generally reserve topical corticosteroids for patients who cannot tolerate or decline intralesional corticosteroid therapy. Cutaneous atrophy is a risk of corticosteroid treatment. Risks of cryotherapy include dyspigmentation and scarring.</p>
Administration considerations are as follows:
<ul>
<li>Intralesional injections of triamcinolone acetonide (concentration of 3 mg/mL) are administered every 4 to 6 weeks and discontinued if there is no response after 3 treatments.</li>
<li>A high-potency corticosteroid is applied twice daily for 2 weeks and then switched to a low-potency corticosteroid. We discontinue topical corticosteroids if there is no response within 2 to 3 months.</li>
<li>Cryotherapy is performed every 4 to 6 weeks. We stop cryotherapy if there is a poor response after 3 to 4 treatments.</li>
</ul>
<p class="extra_spacing_top">Δ Screening for G6PD deficiency should be performed prior to starting dapsone. Patients with G6PD deficiency have an increased risk for hematologic complications from dapsone. Refer to UpToDate content on granuloma faciale for details on dapsone and other treatments.</p></div><div id="graphicVersion">Graphic 141782 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
